Forecasts of COPD mortality in Australia: 2006-2025

BMC Medical Research Methodology

Michael Abramson¹  Michelle Scollo³  Rob J Hyndman⁴  Shahid Ullah²  Bircan Erbas⁵ 

[1] School of Public Health and Preventive Medicine, Alfred Hospital, Monash University, Melbourne 3004, Australia;Flinders Centre for Epidemiology and Biostatistics, School of Medicine, Flinders University, South Australia 5042, Australia;VicHealth Centre for Tobacco Control, The Cancer Council Victoria, 100 Drummond St, Carlton, Victoria 3053, Australia;Department of Econometrics and Business Statistics, Monash University, Clayton 3800, Australia;School of Public Health, La Trobe University, Rm 129, Health Sciences 1, Bundoora, Victoria, 3086, Australia

关键词: Forecasting;    Tobacco consumption;    Functional data analysis;    COPD mortality;   

Others  :  1136826
DOI  :  10.1186/1471-2288-12-17

 received in 2011-01-09, accepted in 2012-02-21,  发布年份 2012

【 摘 要 】

Background

Chronic Obstructive Pulmonary Disease (COPD) is currently the fifth leading cause of death in Australia, and there are marked differences in mortality trends between men and women. In this study, we have sought to model and forecast age related changes in COPD mortality over time for men and women separately over the period 2006-2025.

Methods

Annual COPD death rates in Australia from 1922 to 2005 for age groups (50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84, 85+) were used. Functional time series models of age-specific COPD mortality rates for men and women were used, and forecasts of mortality rates were modelled separately for men and women.

Results

Functional time series models with four basis functions were fitted to each population separately. Twenty-year forecasts were computed, and indicated an overall decline. This decline may be slower for women than for men. By age, we expect similar rates of decline in men over time. In contrast, for women, forecasts for the age group 75-79 years suggest less of a decline over time compared to younger age groups.

Conclusions

By using a new method to predict age-specific trends in COPD mortality over time, this study provides important insights into at-risk age groups for men and women separately, which has implications for policy and program development.

【 授权许可】

   
2012 Erbas et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Australian Government Institute of Health and Welfare: Australia's Health 2008. [http://www.aihw.gov.au/publications/index.cfm/title/10585] webcite 2008. [updated 2008; cited 13/10/2009]. Available from
• [2]Wilson DH, Tucker G, Frith P, Appleton S, Ruffin RE, Adams RJ: Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia, 1993-2003. Med J Aust 2007, 86(8):408-411.
• [3]Hyndman RJ, Ullah MS: Robust forecasting of mortality and fertility rates: a functional data approach. Comput Stat Data Anal 2007, 51(10):4942-4956.
• [4]Australian Government Institute of Health and Welfare: General Record of Incidence of Mortality (GRIM) Books. [http://www.aihw.gov.au/mortality/data/grim_books_national.cfm] webcite 2005. [updated 2005; cited 13/10/2009]. Available from
• [5]Taylor E: New international disease classification. Health Rep 1992, 4(3):331.
• [6]Ramsay JO, Silverman BW: Functional Data Analysis, Springer Series in Statistics. New York: Springer; 1997.
• [7]Ruppert D, Wand MP, Carroll RJ: Semiparametric Regression. New York: Cambridge University Press; 2003.
• [8]Simonoff JS: Smoothing Methods in Statistics. New York: Springer; 1996.
• [9]Hyndman R, Koehler A, Ord JK, Synder RD: Forecasting with Exponential Smoothing: The State Space Approach. Berlin: Springer; 2008.
• [10]Hyndman RJ, Koehler AB, Snyder RD, Gross S: A state space framework for automatic forecasting using exponential smoothing methods. Int J Forecast 2002, 18(3):439-454.
• [11]Goldacre MJ, Duncan M, Cook-Mozaffari P, Griffith M: Mortality rates for common respiratory diseases in an English population 1979-1998: artefact and substantive trends. J Public Health 2004, 26(1):8-12.
• [12]Lacasse Y, Brooks D, Goldstein RS: Trends in the epidemiology of COPD in Canada, 1980-1995. COPD and Rehabilitation Committee of the Canadian Thoracic Society. Chest 1999, 116(2):306-313.
• [13]Kazerouni N, Alverson CJ, Redd SC, Mott JA, Mannino DM: Sex differences in COPD and lung cancer mortality trends-United States, 1968-1999. J Womens Health 2004, 13(1):17-23.
• [14]Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC: Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. Respir Care 2002, 47(10):1184-1199.
• [15]Fuhrman C, Jougla E, Nicolau J, Eilstein D, Delmas MC: Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis. Thorax 2006, 61(11):930-934.
• [16]Royal College of Physicians: Smoking and Health: A Report of the Royal College of Physicians on Smoking in Relation to Cancer of the Lung and Other Diseases. London: Pitman Medical Publishing Co Ltd; 1962.
• [17]Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. Rockville, Maryland; 1964.
• [18]Woodward S: Trends in cigarette consumption in Australia. N Z J Med 1984, 14:405-407.
• [19]Winstanley M, Woodward S, Walker N: Tobacco in Australia; Facts and Issues 1995 Volume 2. [http://www.quit.org.au/quit/FandI/welcome.htm] webcite Journal [serial on the Internet]. 1995. Available from
• [20]Feenstra TL, van Genugten ML, Hoogenveen RT, Wouters EF, Ruttem-Van Molken MP: The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med 2001, 164(6):590-596.
• [21]Mannino DM, Buist A: S. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007, 370(9589):765-773.
• [22]Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, Martinez FJ: Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med 2007, 176(12):1179-1184.
• [23]Chapman KR, Tashkin DP, Pye DJ: Gender bias in the diagnosis of COPD. Chest 2001, 119(6):1691-1695.
• [24]Varkey AB: Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med 2004, 10(2):98-103.
• [25]Hoogendoorn M, Rutten-van Mölken MP, Hoogenveen RT, van Genugten ML, Buist AS, Wouters EF, Feenstra TL: A dynamic population model of disease progression in COPD. Eur Respir J 2005, 26(2):223-233.
• [26]Walters EH, Wood-Baker R: Comment on: "Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia". Med J Aust 2008, 188(4):258-259.
• [27]Matheson MC, Abeysena C, Raven JM, Skoric B, Johns DP, Abramson MJ, Walters EH: How have we been managing chronic obstructive pulmonary disease in Australia? Intern Med J 2006, 36(2):92-99.
• [28]Smyth ET, Wright SC, Evans AE, Sinnamon DG, McMahon J: Death from airways obstruction: accuracy of certification in Northern Ireland. Thorax 1996, 51:239-297.
• [29]McKenzie DK, Frith PA, Burdon JG, Town GI: The COPD plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2003. Med J Aust 2003, 178(Suppl):S7-S39.
• [30]Abramson MJ, Crockett AJ, Frith PA, McDonald CF: COPDX: an update of guidelines for the management of chronic obstructive pulmonary disease with a review of recent evidence. Med J Aust 2006, 184(7):342-345.